Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX
· Real-Time Price · USD
4.67
0.28 (6.38%)
At close: Jun 17, 2025, 1:15 PM
Foghorn Therapeutics Revenue
Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending March 31, 2025, Foghorn Therapeutics generated $5.95M in revenue.
Revenue (ttm)
$22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
$201.8K
Employees
112
Market Cap
260.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|